title: Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).
abstract: A new casomorphin pentapeptide (alpha S1-casomorphin) has been isolated from the sequence of human alpha S1-casein [alpha S1-casein-(158-162)], with the sequence Tyr-Val-Pro-Phe-Pro. This peptide was found to bind with high affinity to all three subtypes of the kappa-opioid receptor (kappa 1-kappa 2). When amidated at the C-terminus, alpha S1-casomorphin amide binds to the delta- and kappa 3-opioid sites. Both alpha S1-casomorphin and its amide inhibit in a dose-dependent and reversible manner the proliferation of T47D human breast cancer cells. This anti-proliferative activity was greater for alpha S1-casomorphin, which was the most potent opioid in inhibiting T47D cell proliferation. In T47D breast cancer cells, other casomorphins have been found to bind to somatostatin receptors in addition to opioid sites. In contrast, alpha S1-casomorphin and its amide do not interact with somatostatin receptors in our system.
authors.affiliation: Laboratory of Experimental Endocrinology, University of Crete School of Medicine and University Hospital, Heraklion, Greece.
authors.forename: M
authors.initials: M
authors.lastname: Kampa
authors.forename: S
authors.initials: S
authors.lastname: Loukas
authors.forename: A
authors.initials: A
authors.lastname: Hatzoglou
authors.forename: P
authors.initials: P
authors.lastname: Martin
authors.forename: P M
authors.initials: PM
authors.lastname: Martin
authors.forename: E
authors.initials: E
authors.lastname: Castanas
mesh_terms: D000595:Amino Acid Sequence; D001667:Binding, Competitive; D001943:Breast Neoplasms; D002364:Caseins / Q000737:chemistry* / Q000378:metabolism* / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D004174:Diprenorphine / Q000494:pharmacology; D020881:Enkephalin, D-Penicillamine (2,5)-; D016308:Enkephalin, Leucine-2-Alanine / Q000494:pharmacology; D004745:Enkephalins / Q000494:pharmacology; D016314:Ethylketocyclazocine / Q000494:pharmacology; D005260:Female; D006801:Humans; D007700:Kinetics; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology*; D017473:Receptors, Opioid, kappa / Q000378:metabolism*
chemical_list: D002364:Caseins; D004745:Enkephalins; D010446:Peptide Fragments; D017473:Receptors, Opioid, kappa; C102368:alpha(S1)-casomorphin; C102369:alpha(S1)-casomorphin amide; D004174:Diprenorphine; D016314:Ethylketocyclazocine; D016308:Enkephalin, Leucine-2-Alanine; D020881:Enkephalin, D-Penicillamine (2,5)-